Oculis Publishes 2025 Consolidated Financial Statements

ZUG, Switzerland, March 05, 2026 (GLOBE NEWSWIRE) -- Following the Company‘s press release published on March 3, the audited consolidated financial statements for the financial year 2025 and the MD&A, which have now been filed with the SEC on form 20-F, are attached.

Attachments

• Oculis 2025 Consolidated IFRS Financial Statements
• Oculis 2025 MD&A
• Oculis ESEF reporting

You May Also Be Interested In

• J&J myeloma drug combo shows survival gains in Phase 3 data
• Tempest Therapeutics names Nancy Freda-Smith to its board
• Limbach names Adam Prior as VP of investor relations